POC CD4 testing improves linkage to HIV care and timeliness of ART initiation in a public health approach: A systematic review and Meta-Analysis

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Vojnov, Lara ^a   Markby, Jessica ^b   Boeke, Caroline ^a   Harris, Lindsay ^a   Ford, Nathan ^b   Peter, Trevor ^a  

^a CLINTON HEALTH ACCESS INITIATIVE   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LABORATORY TEST; LIFE EXPECTANCY; META ANALYSIS; PATIENT CARE; REVIEW; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; HIV INFECTIONS; ODDS RATIO; PATIENT ATTITUDE; POINT OF CARE SYSTEM; PROCEDURES; PUBLIC HEALTH; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; POINT-OF-CARE SYSTEMS; PUBLIC HEALTH; TIME FACTORS; YOUNG ADULT;

EID: 84969785206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155256     Document Type: Review

References (49)

1. Hulgan T, Shepherd BE, Raffanti SP, Fusco JS, Beckerman R, Barkanic G et al. (2007) Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIVinfected persons initiating highly active antiretroviral therapy. J Infect Dis 195: 425-431. PMID: 17205482
2. Kagaayi J, Makumbi F, Nakigozi G, Wawer MJ, Gray RH, Serwadda D et al. (2007) WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. AIDS 21: 1208-1210. PMID: 17502733
3. O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S et al. (1996) Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 334: 426-431. PMID: 8552144
4. Post FA, Wood R, Maartens G (1996) CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM 89: 505-508. PMID: 8759490
5. World Health Organization (2015) Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.
6. Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T et al. (2015) The future role of CD4 cell count for monitoring antiretroviral therapy. The Lancet Infectious Diseases 15: 241-247. doi: 10.1016/ S1473-3099(14)70896-5 PMID: 25467647
7. Gilks CF, Walker AS, Munderi P, Kityo C, Reid A, Katabira E et al. (2013) A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria. PLoS ONE 8: e57580. doi: 10.1371/journal.pone.0057580 PMID: 23437399
8. Govindasamy D, Ford N, Kranzer K (2012) Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 26: 2059-2067. doi: 10.1097/QAD.0b013e3283578b9b PMID: 22781227
9. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD (2012) Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 15: 17383. doi: 10.7448/IAS.15.2.17383 PMID: 23199799
10. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T et al. (2012) Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 17: 1509-1520. doi: 10.1111/j.1365-3156.2012.03089.x PMID: 22994151
11. Rosen S, Fox M (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: e1001056. doi: 10.1371/journal.pmed.1001056 PMID: 21811403
12. UNITAID (2013) HIV/AIDS Diagnostic Technology Landscape, 3rd edition.
13. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM et al. (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378: 1572-1579. doi: 10.1016/S0140-6736(11)61052-0 PMID: 21951656
14. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N (2014) Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc 17: 18809. doi: 10.7448/IAS.17.1.18809 PMID: 24447595
15. Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6: e1000097. doi: 10.1371/journal.pmed. 1000097 PMID: 19621072
16. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536. doi: 10.7326/0003-4819-155-8-201110180-00009 PMID: 22007046
17. Takkouche B, Cadarso-Suárez C, Spiegelman D (1999) Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. American Journal of Epidemiology 150: 206-215. PMID: 10412966
18. Barnabas R, Van Rooyen H, Tumwesigye E, Murnane P, Baeten J, Humphries H et al. (2014) Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study. The Lancet HIV 1: e68-e76. PMID: 25601912
19. Bassett I, Govindasamy D, Erlwanger A, Hyle EP, Kranzer K, Van Schaik N et al. (2014) Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness. PLoS ONE 9: e85197. doi: 10.1371/journal.pone.0085197 PMID: 24465503
20. Brouillette AM, Chien E, Nyegenye W, Tenywa T, Grosz J (2013) Using finger-prick blood collection samples for the Pima POC CD4 device increases access to CD4 testing. 7th IAS Conference on HIV Pathogenesis and Treatment; Kuala Lumpur Abstract WEPE607.
21. Cassim N, Coetzee LM, Schnippel K, Glencross DK (2014) Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa. PLoS ONE 9: e115420. doi: 10.1371/journal.pone.0115420 PMID: 25517412
22. Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K et al. (2015) Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis. PLoS ONE 10: e0117751. doi: 10.1371/journal.pone.0117751 PMID: 25756498
23. De Schacht C, Lucas C, Sitoe NE, Manuel I, Tobaiwa O, Ramanial N et al. (2012) Point-of-care CD4 testing leads to increased uptake of antiretroviral therapy among pregnant women in Gaza province, Mozambique. 19th International AIDS Conference: Abstract no. THPE079.
24. Desai MA, Okal D, Rose C, Ndivo R, Williams T, Otieno F et al. (2015) Point-of-Care CD4 (Pima) Impact on Linkage to Care with Home-Based HIV Testing, Kenya. Conference on Retroviruses and Opportunistic Infections: Abstract #632LB.
25. Dhoot S, Stack R, Madden P, McMillan S, Jones R, Day S (2013) CD4 point-of-care testing to guide management in patients newly diagnosed with HIV. International Journal of STD & AIDS 4.
26. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R (2011) Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr 58: e54-e59. doi: 10.1097/QAI. 0b013e3182303921 PMID: 21857356
27. Fajardo N, Metcalf C, Piriou E, Gueguen M, Maman D, Chaillet P et al. (2014) High frequency of invalid CD4 test results using the Alere Pima CD4 analyzer in field projects in nine countries. 20th International AIDS Conference: Abstract WEPE040.
28. Grundy CL, Medina Lara A, Winogron D, Croucher AP, Batz H-G, Hallett TB et al. (2014) Point-of-care CD4 tests can increase life-years saved with reduced costs compared to flow cytometric CD4. 6th IAS Conference on HIV Pathogenesis and Treatment: Abstract No MOAD0105.
29. Hatzold K, Gudekeya S, Museta M, Maparutza S, Mangwiro A, Bhattacharya G et al. (2011) Improved access to HAART through Point of Care CD4 cell count testing integration into HIV testing and counseling services in Zimbabwe. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention: Abstract No CDD080.
30. Herbert S, Carrick G, Edwards S, Copas A, George B, Long L et al. (2011) Enhancing services for HIVpositive patients: the role of point-of-care CD4 testing. HIV Medicine: Abstract No. P4 12: 15.
31. Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J et al. (2014) The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis. PLoS Med 11: e1001725. doi: 10.1371/journal.pmed.1001725 PMID: 25225800
32. Jani IV, Quevedo JI, Tobaiwa O, Bollinger T, Sitoe NE, Chongo P et al. (2016) Use of mobile phone technology to improve the quality of point-of-care testing in a low resource setting. AIDS accepted.
33. Larson B, Ndibongo B, Bistline K, Xulu T, Brennan A, Long L et al. (2011) Point-of-care CD4 testing after HIV diagnosis to reduce losses to initiation of antiretroviral therapy: an evaluation of a pilot program at the Themba Lethu Clinic, Johannesburg, South Africa. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention: Abstract No MOPE450.
34. Larson B, Schnippel K, Ndibongo B, Long L, Fox M, Rosen S (2012) How to Estimate the Cost of Pointof-Care CD4 Testing in Program Settings: An Example Using the Alere Pima? Analyzer in South Africa. PLoS ONE 7: e35444. doi: 10.1371/journal.pone.0035444 PMID: 22532854
35. Larson B, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L et al. (2012) Rapid Point-of-Care CD4 Testing at Mobile HIV Testing Sites to Increase Linkage to Care. JAIDS Journal of Acquired Immune Deficiency Syndromes 61: e13-e17. PMID: 22659650
36. Larson B, Schnippel K, Brennan A, Long L, Xulu T, Maotoe T et al. (2013) Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough. AIDS Research and Treatment 2013: 1-7.
37. Muchedzi A, Chadambuka A, Chikwinya B, Mahomva A (2012) Evaluating the effect of the use of pointof-care CD4 machines on access to antiretroviral therapy (ART) eligibility screening and ART initiation for HIV-positive pregnant women in Zimbabwe: towards elimination of new paediatric HIV infection by 2015. 19th International AIDS Conference, Abstract no. TUPDE0204.
38. Mwanja A, Brown L, Mtumbuka E, Shayo C, Vojnov L (2013) The introduction of a POC CD4 technology increases patient access to and the impact of CD4 testing. 7th IAS Conference on HIV Pathogenesis and Treatment: Abstract WEPE608.
39. Myer L, Zulliger R, Black S, Pienaar D, Bekker LG (2012) Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. AIDS Care 24: 986-992. doi: 10.1080/ 09540121.2012.668173 PMID: 22519561
40. Myer L, Phillips T, Manuelli V, Mcintyre J, Bekker LG, Abrams E (2015) Implementation and Operational Research. JAIDS Journal of Acquired Immune Deficiency Syndromes 69: e57-e65.
41. Obi A, Jones C, Pizzo E, Vera J, Hart C, Mackie N et al. (2013) CD4 point-of-care testing improves patient satisfaction and reduces recalls to clinic. HIV Medicine: Abstract No. O3 14.
42. Patten GE, Wilkinson L, Conradie K, Isaakidis P, Harries A, Edginton ME et al. (2013) Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa. J Int AIDS Soc 16: 18518. doi: 10.7448/IAS.16.1.18518 PMID: 23830642
43. Rioja MR, Nzuobontane D, Munyaburanga F, Khan EM, Muffih PT, Shang J et al. (2013) CD4 count testing capacity in rural health districts in Cameroon through point-of-care technology. 7th IAS Conference on HIV Pathogenesis and Treatment: Abstract No WEPE609.
44. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwengyana C, Malete G et al. (2015) Rapid ART Initiation Reduces Loss Between HIV Testing and Treatment: The RapIT Trial. Conference on Retroviruses and Opportunistic Infections: Abstract #1091.
45. Tsibolane Y, Van Turha L, Maharaj K, Rose A, Boeke C, Peter T et al. Point-of-Care CD4 technology implementation in Free State, South Africa associated with better patient health outcomes. manuscript in preparation.
46. Van Rooyen H, Barnabas R, Baeten J, Phakathi Z, Joseph P, Krows M et al. (2013) High HIV Testing Uptake and Linkage to Care in a Novel Program of Home-Based HIV Counseling and Testing With Facilitated Referral in KwaZulu-Natal, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 64: e1-e8. doi: 10.1097/QAI.0b013e31829b567d PMID: 23714740
47. World Health Organization (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
48. AlereHIV.com Studies and Implementation Map. Available: http://www.alerehiv.com/ww/home/studiesand-implementation.html via the Internet.
49. Jani IV, Peter TF (2013) How point-of-care testing could drive innovation in global health. N Engl J Med 368: 2319-2324. doi: 10.1056/NEJMsb1214197 PMID: 23758238